Acorn’s management team comprises seasoned executives with substantial life science industry experience ranging from start-ups to global pharmaceutical giants. During their respective careers, each person has participated in the building of pharmaceutical companies and the development of numerous drugs that have been successfully brought to market.

Alan J. Jacobs, M.D., Ph.D.
Co-Founder, Chairman and Chief Executive Officer

Dr. Alan Jacobs is currently the CEO and a co-founder of Acorn Biomedical, Inc. Dr. Alan Jacobs has 10 years of experience in drug and biologic product development. Most recently, Dr. Jacobs was the Chief Medical Officer and Vice President of Clinical Research at Stem Cells, Inc. Dr. Jacobs has held prior management positions in clinical development at Titan Pharmaceuticals (including a joint development program with Schering AG), Layton Bioscience, and Elan Pharmaceuticals. During his tenure at the aforementioned companies, he led several products through the IND-enabling process and conducted first in-human and phase 2 clinical trials of new biologic entities and a novel drug/device combination product. Dr. Jacobs earned his B.S. degree in Electrical Engineering from Cornell and M.S. degree in Electrical Engineering from Stanford, and received his M.D. and Ph.D. degrees from the University of Pennsylvania.

Richard C. Bulman, Esq.
General Counsel

Mr. Bulman currently serves as the General Counsel for Acorn Biodical, Inc.  Mr. Bulman is a corporate and technology lawyer with more than 20 years experience who has served in executive and legal positions with such organizations as KL/Gates (formerly Kirkpatrick & Lockhart), IVAX Corporation, American Lawyer Media, LLC, Akerman Senterfitt, Diversified Communications Industries, Ltd., Empire of America and the State of New York. 

Charles J. Betlach, II, Ph.D.
Director

Mr. Betlach is currently a Director of Concordia Pharmaceuticals, Inc. and a private investor. From 1991 – 1998, Dr. Betlach was co-founder and Executive Vice President, Research and Development of Sano Corporation. Prior to Sano Corporation, Dr. Betlach held various research positions at Key Pharmaceuticals, Inc. and Schering-Plough Corporation.